secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K/A
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001654954-24-007479
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience amends 8-K to correct date typo in director stock award from 2023
--------------------------------------------------------------------------------

- Corrects date in Item 1.01 from erroneous date to December 29, 2023.
- Board approved 261,619 shares to three non-employee directors for unpaid 2023 fees of $172,670.
- Shares issued at $1.20 per share (Dec 29, 2023 close), grossed up for taxes at 45%.
- Directors Cornell (95k), Masterson (85k), Maggiore (82k) accepted grants on June 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424007479/0001654954-24-007479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424007479/zivo_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-007479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer